New data on atopic dermatitis show treatment gaps, heavy reliance on dermatology APPs, and wide state variation in specialist supply
|Articles|February 20, 2013
Generic Rx Plan Lowers Medicare Psych Costs
Advertisement
Providing generic drug coverage to mentally ill Medicare beneficiaries who hit the drug coverage gap cost less overall than leaving them with no drug coverage, a study found.
Healthcare costs were lower by roughly 3% among Medicare beneficiaries with bipolar disorder who had generic-only coverage rather than no drug coverage, and 5% lower for those with schizophrenia and generic-only coverage, according to a study published in the February issue of
Read the full story:
Source: MedPage Today
Advertisement
Related to this article
Average stand-alone Part D premiums are projected to rise by less than $1 a month as a temporary subsidy program ends after 2026.
Aligning financial incentives with patient-centered care is becoming an increasingly complex path to navigate within oncology.
MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Advertisement
Advertisement
Trending on AJMC
1
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
2
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
3
FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion
4
Preparing Practices for the Next Era of Hepatitis B Care
5